A series of recent events have accelerated the impact retail investors are having on the equity markets. We discuss how to better understand and take advantage of this movement. In addition, we explore how to manage COVID-19 vaccine policies in the workplace, what type of disclosure is appropriate for your news, and more...all in this month’s Westwicke Wisdom.
Three biotechs raised a combined $639 million in newly priced stock offerings in the first quarter of 2021. This continues a boom for biotech IPOs that began in 2013 but has soared to new heights during the COVID-19 pandemic.